Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Emerging Therapies
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Web Exclusives
,
Emerging Therapies
Read More ›
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors
Web Exclusives
,
Emerging Therapies
Read More ›
Two New Therapies Active in NSCLC with EGFR/HER2 Exon 20 Mutations
By
Phoebe Starr
Web Exclusives
,
Emerging Therapies
Read More ›
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
By
Phoebe Starr
Emerging Therapies
,
Web Exclusives
Read More ›
Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia
By
Wayne Kuznar
Web Exclusives
,
Emerging Therapies
Read More ›
First-in-Class Sotatercept Improves Hemoglobin Levels in Anemic Patients with Myelofibrosis
By
Wayne Kuznar
Web Exclusives
,
Emerging Therapies
Read More ›
Mogamulizumab, Anti-CCR4 Antibody, Improves Survival in Patients with Advanced Cutaneous T-Cell Lymphoma
By
Charles Bankhead
Web Exclusives
,
Emerging Therapies
Read More ›
2014 Oncology Pipeline Looks Impressive
By
Wayne Kuznar
Emerging Therapies
Read More ›
The Developing Treatment Role of Bendamustine
By
Susanne Liewer, PharmD, BCOP
Emerging Therapies
Read More ›
Toxicity of Bendamustine Therapy
By
Susanne Liewer, PharmD, BCOP
Emerging Therapies
Read More ›